Literature DB >> 15544632

Does immune activation continue during an attack-free period in familial Mediterranean fever?

U Musabak1, A Sengul, C Oktenli, S Pay, Z Yesilova, L Kenar, S Y Sanisoglu, A Inal, A Tuzun, A Erdil, S Bagci.   

Abstract

Although some information is available regarding immune activation in familial Mediterranean fever (FMF), little is known about either peripheral blood T cell activation marker expression or the T cell proliferative response to phytohaemagglutinin (PHA). In the present study, we aimed to investigate the percentages of peripheral blood lymphocyte subsets, T cell expression of cellular activation markers (CD25, CD69, HLA-DR), the T cell response to PHA and serum levels of soluble interleukin-2 receptor (sIL-2R) and interleukin (IL)-10 in patients with FMF. Forty patients with FMF were enrolled into the study. Control groups were sex- and age-matched and consisted of 20 healthy blood donors and 15 patients with inactive Behcet's disease. The patients with FMF in an attack period had higher levels of sIL-2R than those in an attack-free period, and also in comparison with both control groups. The levels of sIL-2R were also found to be higher in patients with FMF in an attack-free period than those in both control groups. The mean levels of IL-10 were found to be lower in patients with FMF in an attack-free period than those in an attack period and were also lower than those in the healthy controls. In an acute attack period, the absolute counts of CD3+HLA-DR+, CD4+CD69+, CD8+CD25+ and CD8+CD69+ T cells in peripheral blood samples were also higher than those in both control groups. Both the percentages and absolute counts of CD4+CD69+ T cells in peripheral blood samples of patients with FMF in an attack-free period were slightly but significantly higher than those in the healthy controls. In conclusion, our study indicates that the T cell system is abnormally activated in patients with FMF in both the attack and attack-free period and that decreased IL-10 levels may create a tendency to perpetuate subclinical immune activation in the attack-free period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544632      PMCID: PMC1809227          DOI: 10.1111/j.1365-2249.2004.02632.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  [Immune disorders in periodic disease].

Authors:  K G Karagezian; E E Nazaretian; A M Zavgorodniaia; K O Ovnanian
Journal:  Klin Med (Mosk)       Date:  2000

2.  Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins.

Authors:  B J Prakken; U Wendling; R van der Zee; V P Rutten; W Kuis; W van Eden
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

3.  Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter.

Authors:  Roland Lang; Robert L Rutschman; David R Greaves; Peter J Murray
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 4.  Structure of IL-10 and its role in autoimmune exocrinopathy.

Authors:  I Saito
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

5.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

Authors:  M Centola; G Wood; D M Frucht; J Galon; M Aringer; C Farrell; D W Kingma; M E Horwitz; E Mansfield; S M Holland; J J O'Shea; H F Rosenberg; H L Malech; D L Kastner
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

Review 6.  Familial mediterranean fever - a review and update.

Authors:  H Orbach; E Ben-Chetrit
Journal:  Minerva Med       Date:  2001-12       Impact factor: 4.806

7.  Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever.

Authors:  H Direskeneli; H Ozdogan; C Korkmaz; T Akoglu; H Yazici
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

8.  Regulatory activity of autocrine IL-10 on dendritic cell functions.

Authors:  S Corinti; C Albanesi; A la Sala; S Pastore; G Girolomoni
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

9.  Acute phase response in familial Mediterranean fever.

Authors:  C Korkmaz; H Ozdogan; O Kasapçopur; H Yazici
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

Review 10.  The dual role of IL-10.

Authors:  Simone Mocellin; Monica C Panelli; Ena Wang; Dirk Nagorsen; Francesco M Marincola
Journal:  Trends Immunol       Date:  2003-01       Impact factor: 16.687

View more
  23 in total

1.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Authors:  Eren Erken; Huseyin T E Ozer; Ramazan Gunesacar
Journal:  Rheumatol Int       Date:  2006-01-06       Impact factor: 2.631

2.  Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.

Authors:  Veysel Ozalper; Muammer Kara; Alpaslan Tanoglu; Ibrahim Cetındaglı; Coskun Ozturker; Yusuf Hancerlı; Serdar Hıra; Kemal Kara; Yavuz Beyazıt; Yusuf Yazgan
Journal:  Clin Rheumatol       Date:  2017-01-10       Impact factor: 2.980

3.  High frequency of MEFV gene mutations in patients with myeloid neoplasm.

Authors:  Cagatay Oktenli; Ozkan Sayan; Serkan Celik; Alev A Erikci; Yusuf Tunca; Hakan M Terekeci; Elcin Erkuvan Umur; Yavuz S Sanisoglu; Deniz Torun; Fatih Tangi; Burak Sahan; Selim Nalbant
Journal:  Int J Hematol       Date:  2010-05-01       Impact factor: 2.490

4.  Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells.

Authors:  Jaehyung Park; Michael H Gerber; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2014-03-25       Impact factor: 4.396

Review 5.  High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

Authors:  Cagatay Oktenli; Serkan Celik
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

Review 6.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

7.  Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever.

Authors:  Hale Sakallı; Oznur Kal
Journal:  Clin Rheumatol       Date:  2013-04-17       Impact factor: 2.980

8.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

9.  Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters.

Authors:  Hakan M Terekeci; Eralp R Ulusoy; Nezihi M Kucukarslan; Selim Nalbant; Cagatay Oktenli
Journal:  Rheumatol Int       Date:  2008-07-23       Impact factor: 2.631

10.  High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia.

Authors:  Ozkan Sayan; Emrah Kilicaslan; Serkan Celik; Fatih Tangi; Alev A Erikci; Osman Ipcioglu; Yavuz S Sanisoglu; Selim Nalbant; Cagatay Oktenli
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-21       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.